Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $3,365 - $13,944
12,021 Added 8.46%
154,111 $50,000
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $150,615 - $237,290
142,090 New
142,090 $164,000
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.95 $70,765 - $121,046
-62,075 Reduced 60.78%
40,063 $74,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $9,181 - $16,755
7,651 Added 8.1%
102,138 $135,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $134,717 - $290,924
82,649 Added 698.17%
94,487 $159,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $8,641 - $44,274
11,838 New
11,838 $37,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.